ARCHIVES

Amgen Cancels Rilotumumab Trials in Gastric Cancer

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

Herberman Outlines NSABP restructuring In Plan To NCI

May 6, 1994

DRCCA Staff Boom To 145, Still Growing, Still Looking for People

November 25, 1983

NCI-Approved Clinical Trials

June 24, 2005

Lasker Official Urges Congressional Support Of NCI Bypass Budget

April 20, 1990

M.D. Anderson, SWOG To Use Web-Based Software To Expand Access To Trials.

September 29, 2000

NCI Program: reports Urges Expansion of Surveillance Program To Better Explain Trends

April 30, 1999